Hungary leads clinical trials in Europe
The annual average of Hungarians participating as patients in clinical tests is somewhere between 15,000 and 20,000 the chairman of the Association of Innovative Pharmaceutical Companies told Hungarian economic daily Napi Gazdaság today.
The ratio puts Hungary in the leading position in Europe, while globally, the country ranks fifth in terms of the number of clinical trial participants, Zoltán Jakab said. He added that drug companies spend approximately HUF 80-90 bln annually on clinical trials in the country.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.